Skip to content
AkademScholar

Products

For developers

AkademBasesoonDeveloper API
Authors

Zukela Ruzi

Last known institution:
Xinjiang Technical Institute of Physics & Chemistry
4
h-index
2
i10-index
36
Citations
5
Works
Trends over time

Performance over time

Citation overview

Publications (bars) and citations (line) by year

  • Publications
  • Citations
01205101520202120222023202420252021: Publications 2, Citations 12022: Publications 1, Citations 102023: Publications 1, Citations 142024: Publications 0, Citations 32025: Publications 1, Citations 8

Citation history

05101520202120222023202420252021: Citations 12022: Citations 102023: Citations 142024: Citations 32025: Citations 8

Publication history

012202120222023202420252021: Publications 22022: Publications 12023: Publications 12024: Publications 02025: Publications 1

h-index evolution

Cumulative h-index by year

01345202120222023202420252021: h-index 12022: h-index 22023: h-index 32024: h-index 32025: h-index 4

Most-cited works

  1. Synthesis and anticancer activity of ethyl 5‐amino‐1‐<i>N</i>‐substituted‐imidazole‐4‐carboxylate building blocks202111 citations
  2. <scp>2‐substituted</scp> tricyclic oxazolo[5,4‐<i>d</i>]pyrimidine library: Design, synthesis, and cytotoxicity activity202111 citations
  3. Novel pyrazolo[3,4-d]pyrimidines as potential anticancer agents: Synthesis, VEGFR-2 inhibition, and mechanisms of action20228 citations
  4. Discovery of novel (E)-1-methyl-9-(3-methylbenzylidene)-6,7,8,9-tetrahydropyrazolo[3,4-d]pyrido[1,2-a]pyrimidin-4(1H)-one as DDR2 kinase inhibitor: Synthesis, molecular docking, and anticancer properties20236 citations
  5. Scaffold-Hopping Design and Synthesis of Thieno[3,2-d]pyrimidines: Anticancer Activity, Apoptosis Induction, and In Silico Inhibition of CDKs20250 citations